Rotavirus, Live

CHEMBL6068358 Phase 4 معتمد Vaccine component
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Rotavirus live is a live oral vaccine component containing attenuated rotavirus strains used to prevent severe gastroenteritis caused by rotavirus infection in infants. It stimulates active humoral and mucosal immunity by mimicking natural infection without causing serious disease. The vaccine has substantially reduced hospitalizations due to rotavirus-associated diarrhea worldwide.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

Rotavirus live is a live oral vaccine component containing attenuated rotavirus strains used to prevent severe gastroenteritis caused by rotavirus infection in infants. It stimulates active humoral and mucosal immunity by mimicking natural infection without causing serious disease. The vaccine has substantially reduced hospitalizations due to rotavirus-associated diarrhea worldwide.

Yes, Rotavirus, Live is an approved drug. It has reached clinical phase 4. It is classified as a Vaccine component.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6068358. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.